Metro AG
F:B4B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Metro AG
F:B4B
|
DE |
|
Benitec Biopharma Inc
NASDAQ:BNTC
|
US |
|
D
|
DRDGOLD Ltd
SWB:DUB1
|
ZA |
|
A
|
Avarone Metals Inc
CNSX:AVM.X
|
CA |
|
K
|
Kinross Gold Corp
XMUN:KIN2
|
CA |
|
First Graphene Ltd
ASX:FGR
|
AU |
|
B
|
Baytex Energy Corp
F:B5X
|
CA |
|
C
|
China Pacific Insurance Group Co Ltd
XMUN:75C
|
CN |
|
L
|
Liberty Global PLC
NASDAQ:LBTYK
|
UK |
|
01 Communique Laboratory Inc
XTSX:ONE
|
CA |
|
S
|
Starbucks Corp
F:SRB
|
US |
|
Q
|
Qualys Inc
F:3L7A
|
US |
|
F
|
flatexDEGIRO AG
SWB:FTK
|
DE |
|
T
|
Tencent Holdings Ltd
XMUN:NNND
|
CN |
|
L
|
Lonza Group AG
XMUN:LO3
|
CH |
|
Innospec Inc
NASDAQ:IOSP
|
US |
|
M
|
Manulife Financial Corp
XMUN:MLU
|
CA |
|
I
|
iQ International AG
XETRA:IQL1
|
CH |
|
A
|
Applied Optoelectronics Inc
SWB:A59
|
US |
|
Repay Holdings Corp
NASDAQ:RPAY
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is B4B's stock price target?
Not Available
B4B does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Metro AG?
Projected CAGR
2%
Over the last 8 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 4 years is 2%.
What is the Operating Income forecast for Metro AG?
Projected CAGR
28%
Over the last 8 years, the compound annual growth rate for Operating Income has been -21%. The projected CAGR for the next 4 years is 28%.